Committee for Advanced Therapies adopts first classification recommendation for an advanced therapy medicinal product.

The European Medicines Agency's (EMEA) Committee for Advanced Therapies (CAT) has adopted its first scientific recommendation on classification of an advanced therapy medicinal product. Advanced therapy medicinal products are medicines for human use that are based on gene therapy, somatic cell therapy or tissue engineering. They offer groundbreaking new treatment opportunities for diseases and injuries of the human body. Because advanced therapy medicinal products are very complex and science in this field is developing rapidly, there are often questions whether or not a product can be classified as an advanced therapy medicinal product, often because these products are at the border …